NR3C1 and breast carcinoma: It can be inhibited by mifepristone (as can be GRα) (2), in turn, ARA70β, an AR coactivator, has been found in MCF-7 breast cancer and PC3 prostate cancer lines and was shown to intensively stimulate the expression of NR3C1, which leads to preferential overexpression of GRβ [179].